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Following traumatic brain injury, there is an enhanced cell proliferative and 
neurogenic response in the young adult hippocampus, which may be associated with 
innate cognitive recovery. However, in the aged brain, an increased level of 
inflammatory cell responses was observed following injury concomitant to decreased 
hippocampal neurogenesis and cognitive recovery in the aging population.  This 
suggests that excessive inflammation produced in the injured aging brain has a 
detrimental effect on neurogenesis and cognitive function.  In this study, we examined 
the effect of anti-inflammatory treatment with minocycline on cell proliferation and 
generation of new neurons in the dentate gyrus (DG) of the hippocampus in both young 
and aged rats.  Fisher 344 rats aged at 3 months and 20 months were subjected to a 
moderate lateral fluid percussion injury (LFPI) or cortical impact injury (CCI).  
Minocycline was administered intraperitoneally starting either at 30 minutes or 4 hours 
 xi 
post-injury, thereafter twice daily for 2 days.  BrdU was injected at 2 days post-injury to 
label injury-induced proliferating cells.  To examine the effect of minocycline on cell 
proliferation, generation of new neurons, and inflammatory cell response at the acute 
stage post-injury, the rats were perfused 3 days post-injury. Brain sections were 
immunostained for BrdU and early neuronal marker doublecortin (DCX). The results 
show that short-term anti-inflammatory treatment with minocycline reduces the cell 
proliferative response, presumably inflammatory cell responses, in young and aged rats 
following LFPI and CCI injury, and enhances generation of new neurons in the 
hippocampus in both young and aged rats following LFPI and in aged rats following CCI 
injury. Therapies that enhance hippocampal neurogenesis may also have potential to 
improve cognitive recovery following TBI. 
 
 
 1 
CHAPTER 1 - INTRODUCTION 
Traumatic brain injury (TBI) is a serious disorder that can result in severe 
behavioral and cognitive deficits. TBI is the leading cause of morbidity and mortality 
after trauma and affects 3 out of every 1,000 Americans each year (Dutton and 
McCunn, 2003). Post-traumatic cerebral inflammation, a secondary consequence of 
TBI, is characterized by glial activation, leukocyte recruitment, and upregulation and 
secretion of cytokines and chemokines (Ziebell and Morganti-Kossmann, 2010; 
Cederberg and Siesjö, 2009). As the primary mediators of the inflammatory response to 
CNS trauma, microglia play a vital role in the injured brain. While short-term microglial 
activation is necessary to remove dying and damaged neurons and promote tissue 
repair, chronic microglial activation is considered to be the most damaging response of 
microglia to injury. Associations between damaged neurons and uncontrolled, 
hyperactivated microglia can result in a self-propagating positive feed-forward loop that 
leads to dysregulated and prolonged microglial activation and neuronal cell death, thus 
driving the chronic progression of neurodegeneration. 
The hippocampus is particularly vulnerable to insults (Dash et al., 2001), and 
brain trauma is often characterized by learning, memory, and cognitive deficits (Witgen 
et al., 2005). However, these deficits may spontaneously recover over time, suggesting 
that there are innate repair and regeneration mechanisms that exist within the brain. 
Previous studies from our laboratory and others have shown a significant increase in 
cell proliferation in the hippocampal dentate gyrus (DG) in both injured juvenile and 
adult rats after lateral fluid percussion injury and controlled cortical impact injury (Sun et 
al., 2005; Rice et al., 2003; Chirumamilla et al., 2002; Dash et al., 2001). These injury-
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induced newly proliferating cells are capable of differentiating into neurons and 
integrating into the existing hippocampal circuitry, and thus may contribute to the 
potential of innate cognitive recovery following TBI (Sun et al., 2007).  
It is well known that aged patients recover to a lesser extent than younger 
patients following TBI, but the mechanisms underlying this age-related disparity are not 
fully understood (Hamm et al, 1992; Sun et al, 2005). Although new neurons are 
continually generated throughout adulthood, multiple studies support that there is an 
80% decline in neural stem cell proliferation and neurogenesis in the normal aged brain 
(Seki and Arai, 1995; Olariu et al., 2007; Galvan and Jin, 2007; Kuhn et al., 1996; Rao 
et al., 2006). Additional evidence indicates that in the aged brain, microglia when 
activated exhibit an amplified inflammatory response (Cekic and Stein, 2010; Loane and 
Byrnes, 2010). Our laboratory has observed that the injury-induced proliferative 
response in the aged brain predominately generates microglial cells, and that newly 
generated neurons fail to survive in this environment for an extended period of time 
(unpublished data from the Sun laboratory). These findings led us to hypothesize that 
enhanced levels of inflammation in the injured aged brain may contribute to reduced 
neurogenesis and cognitive function, and that hippocampal neurogenesis in response to 
injury can be restored by inhibiting the inflammatory response in the aged brain. To test 
this hypothesis, we administered minocycline treatments to young adult and aged rats 
to assess whether anti-inflammatory treatment could enhance hippocampal 
neurogenesis after injury, particularly in the aged brain where microglia exhibit an 
amplified response. 
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EPIDEMIOLOGY OF TBI 
 Traumatic brain injury (TBI) is a major global health concern and has affected 
approximately 57 million people worldwide, resulting in approximately 10 million deaths 
and hospitalizations each year. An estimated 1.5 million Americans sustain a TBI 
annually, making it a leading cause of death and life-long disability in the United States 
(McArthur et al., 2006). These injuries result in 1.1 million emergency department visits, 
230,000 hospitalizations in which patients survive, and 80,000 people that experience 
long-term disability (Thurman et al., 1999a). The CDC estimates that TBI is responsible 
for one-third of all injury-related deaths, with approximately 50,000 Americans dying 
each year following TBI (McArthur et al., 2006; Langlois et al., 2006). The populations at 
the highest risk are adolescents, young adults, and the elderly. The incidence of TBI is 
twice as high among males as it is among females, and adults aged 75 years and older 
have the highest incidence of hospitalizations following TBI, mainly due to falls (Langlois 
et al., 2006). Motor vehicle crashes, falls, and violence are the most common causes of 
TBI (Thurman et al., 1999b; McArthur et al., 2006). Blasts are the leading cause of 
military-associated TBI. Other major causes of TBI include sports and recreational 
activities (Langlois et al., 2006). 
 Many people who survive TBI are faced with permanent neurologic problems and 
disabilities including cognitive, behavioral, emotional, and sensory and motor 
impairments (Hilton, 1994; Langlois et al., 2006). Even mild TBI can result in long-term 
cognitive deficits that may interfere with an individual’s ability to carry out daily tasks or 
return to work (Langlois et al., 2006). A person’s career and social and family 
relationships may be profoundly and permanently altered following TBI. Cognitive 
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functional deficits may cause the loss of communication skills and memory, 
organizational and problem-solving skills, decreased attention span, and impaired 
concentration (Thurman et al., 1999c). Emotional instability, personality changes, 
agitation and aggressiveness, and impulsiveness may be a part of the injury-induced 
behavioral sequelae typical of TBI (Hilton, 1994). In elderly persons, there is a 1.5 times 
increased risk of depression and a 2.3 to 4.5 times increased risk of Alzheimer’s 
disease depending on injury severity, making complications due to TBI especially 
difficult for this age group (Langlois et al., 2006).  
EXPERIMENTAL TBI 
 TBI can result in both focal and diffuse injury to brain tissue. The mechanisms of 
injury include impact, rotational and inertial effects, and the combination of impact with 
rotation. The type and severity of injury depends on the amount of energy transferred to 
the head, the duration of injury, and the site of impact (McArthur et al., 2006). Focal 
injuries are those that are caused by a blow to the head at the site of impact. It is 
estimated that two-thirds of deaths from brain injury are due to focal injuries. Diffuse 
injuries include those that result in severely dysfunctional and vegetative states as well 
as mild concussive brain injuries. Severe diffuse injuries are the primary cause of 
persistent neurological disability (Davis, 2000). The profile of injury typically seen in 
human TBI represents a combination of focal and diffuse injury (McAllister, 2011).  
In the laboratory setting, various experimental animal models are used to study 
the effects of TBI (McArthur et al., 2006). In rodents, fluid percussion injury (FPI) is the 
most widely used TBI model as it produces many of the pathologies observed in human 
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TBI, such as neuronal loss, gliosis, and perturbations in metabolic and ionic 
homeostasis (Witgen et al., 2005; Dixon et al., 1987). With this model, injury levels can 
be graded, where lower magnitudes of injury produce an injury similar to a concussion, 
with brief neurological and physiological disruptions in the absence of remarkable 
structural damage, and a higher magnitude of injury produces greater neurological 
deficits, death, and widespread structural damage (Dixon et al., 1987). The controlled 
cortical impact (CCI) model is often used to study focal brain injuries. The CCI model 
uses a pneumatically driven impactor to induce focal TBI and causes significant cortical 
tissue loss at the site of impact as well as hippocampal neuronal cell loss (Dixon et al., 
1991).  
PATHOPHYSIOLOGY OF TBI 
Although they are fundamentally different, focal and diffuse injuries share 
common mechanisms in the pathophysiology of TBI (McAllister, 2011). Primary injury 
results from immediate disruption of brain tissues following mechanical impact. Primary 
injuries include focal injuries, diffuse injuries, penetrating injuries, and fractures (Davis, 
2000). As a result, complex cellular and molecular cascades constitute the secondary 
injury processes that are initiated and progress over a duration of hours to days after 
the primary injury. A secondary injury cascade follows and causes the additional 
pathophysiology in the brain, significantly contributing to poor prognosis following TBI 
(Ray et al., 2002). These secondary responses includes changes in cerebral blood flow, 
local and systemic inflammation, oxygen free radical generation, ischemia, edema, 
increased intracranial pressure (ICP), apoptosis of neural cells, and excitotoxicity 
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(Dutton and McCunn, 2003; Davis, 2000; McAllister, 2011). The inflammatory cascade 
that is induced via the secondary response can be both beneficial or detrimental, as it is 
a necessary part of healing yet harmful if exaggerated and uncontrolled (Dutton and 
McCunn, 2003). Repair responses may also occur following TBI in an attempt to 
promote functional recovery and regeneration of damaged neurons (Ray et al., 2002). 
INFLAMMATORY RESPONSE TO TBI 
Inflammation is a stereotypical reaction to tissue damage and has been 
extensively reported in both experimental and clinical TBI. Cerebral inflammation in 
response to trauma is a complex and multifactorial process characterized by glial 
activation, leukocyte recruitment, and upregulation and secretion of cytokines and 
chemokines (Ziebell and Morganti-Kossmann, 2010; Cederberg and Siesjö, 2009). 
Post-traumatic inflammation had previously been thought to be deleterious for the 
injured brain. However, recent studies suggest that inflammation has both beneficial 
and detrimental roles, but the mechanisms underlying this dichotomy are largely 
unknown (Ziebell and Morganti-Kossmann, 2010; Cederberg and Siesjö, 2009). In order 
to achieve the benefits, the inflammatory response must be controlled and persist for a 
defined period of time. However, sustained, excessive, or inappropriate inflammation is 
the cause of numerous neuropathologies, including multiple sclerosis, Alzheimer’s 
disease, and Parkinson’s disease (Ziebell and Morganti-Kossmann, 2010; Lucas et al., 
2006). Since the post-traumatic inflammatory response occurs after the initial insult and 
partially parallels the development of secondary tissue damage, there has been much 
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focus on the possibility of inhibiting particular components of inflammation to reduce 
secondary damage (Cederberg and Siesjö, 2009).  
The inflammatory cascade induced by brain trauma is mediated by the release of 
pro- and anti-inflammatory cytokines, which are rapidly upregulated in response to 
pathological or stressful situations yet barely detectable in healthy tissue (Ziebell and 
Morganti-Kossmann, 2010; Lucas et al., 2006). The role of neuroinflammation in the 
pathophysiology of TBI is controversial due to the dual role of cytokines in various 
neuropathologies, as they can contribute to tissue repair as well as tissue destruction 
(Morganti-Kossmann et al., 2001). Pro-inflammatory cytokines include interleukin (IL)-1# 
and IL-1", tumor necrosis factor (TNF)-#, interferon-!, and IL-6, and are thought to 
initiate inflammation via upregulation of adhesion molecules, release of chemokines, 
activation of inflammatory cells, and production of nitric oxide (NO) and reactive oxygen 
species (ROS) (Lucas et al., 2006). In contrast, anti-inflammatory cytokines, such as IL-
10, IL-4, IL-13, and transforming growth factor (TGF)-", function to downregulate and 
counteract inflammatory and cytotoxic events (Cederberg and Siesjö, 2009). 
Chemokines, or chemotactic factors, have the ability to attract inflammatory cells to the 
injured site (Morganti-Kossmann et al., 2001).  
Post-traumatic edema formation is a secondary consequence of TBI and results 
in the breakdown of the blood-brain barrier (BBB) and subsequent cytotoxic events and 
vascular leakage (Ray et al., 2002; Lenzlinger et al., 2001). The impairment of the BBB 
in the acute post-traumatic period allows the entry of circulating neutrophils, monocytes, 
and lymphocytes to the site of injury (Ziebell and Morganti-Kossmann, 2010; Lucas et 
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al., 2006). The disruption of the BBB and subsequent accumulation of blood-borne 
immune cells within the parenchyma has been observed in a variety of experimental TBI 
models as well as in human TBI (Ziebell and Morganti-Kossmann, 2010; Lenzlinger et 
al., 2001). These activated cells release an array of substances that are highly toxic to 
cells including prostaglandins, free radicals, and pro-inflammatory cytokines, which then 
induce the expression of chemokines and cell adhesion molecules and mobilize 
immune and glial cells to the injured site (Ziebell and Morganti-Kossmann, 2010; 
Cederberg and Siesjö, 2009). Eventually, production of anti-inflammatory mediators 
suppresses humoral and cellular immune activation (Ziebell and Morganti-Kossmann, 
2010). With time, repair mechanisms seal the sites of BBB leakage. However, a period 
of time exists in which the endothelium in the damaged region remains permeable to 
small molecules, which results in sustainment of an altered homeostasis of the brain 
parenchyma and continued impairment of neuronal function. This prolonged 
permeability allows for a window of opportunity in which drugs can reach the region of 
injured brain tissue when they would otherwise be excluded from the CNS (Ziebell and 
Morganti-Kossmann, 2010). 
Neuronal dysfunction or death after injury or disease ultimately results in the loss 
of CNS functions (Raghupathi, 2004). As the primary responders to CNS insults, glial 
cells may play a vital role in the determination of clinical outcome (Sofroniew, 2005). 
The activation of microglia is one of the central inflammatory responses to brain injury. 
Microglia represent 10-20% of the total cell population in the adult CNS and function as 
the primary mediators of the brain’s immune response to infection, injury, and disease 
(Loane and Byrnes, 2010). Resident microglia in the CNS have an innate inflammatory 
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capacity and play several roles in the injured brain (Cederberg and Siesjö, 2009; Ziebell 
and Morganti-Kossmann, 2010). Whether the microglial response to injury is beneficial 
or detrimental is under debate, with strong evidence of a dual role and differential 
activation (Loane and Byrnes, 2010; Hailer, 2008). However, it is important to note that 
microglial responses vary depending on the severity of injury and injury model (Loane 
and Byrnes, 2010).  
The chief functions of microglia are to constantly survey their microenvironment 
and detect any noxious agents or injurious processes. They clear toxic substances and 
cellular debris after various kinds of tissue destruction by phagocytosis in order to 
maintain cellular homeostasis in the CNS (Loane and Byrnes, 2010; Hailer, 2008). In 
the CNS, resident microglia react to neuronal injury and BBB disruption caused by the 
initial insult within minutes and can become chronically activated (Ramlackhansingh et 
al., 2011). Chronic microglial activation persists weeks and months after the initial brain 
injury (Loane and Byrnes, 2010). Microglia undergo morphological and behavioral 
changes in response to injury. When activated, microglia contract their processes and 
take on an ameboid morphology similar to that of peripheral macrophages, and then 
proliferate and migrate toward the injured tissue (Loane and Byrnes, 2010; Hailer, 
2008). With this transformation, microglia become indistinguishable from blood-borne 
macrophages and function as antigen-presenting cells (Ramlackhansingh et al., 2011). 
Activated microglia secrete cytokines and trophic factors that can exert protective or 
harmful effects on neighboring cells (Lucas et al., 2006). 
The view that microglia have a detrimental effect in the CNS following TBI is 
supported by their release of vast numbers of cytotoxic chemicals and their association 
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with neuronal cell death (Loane and Byrnes, 2010; Hailer, 2008). Numerous studies 
have reported that microglia release pro-inflammatory mediators, including pro-
inflammatory cytokines, chemokines, NO, and superoxide free radicals that produce 
ROS and reactive nitrogen species (RNS) after brain trauma. These neurotoxic 
substances contribute to neuronal dysfunction and cell death following injury (Hailer, 
2008). Although short-term microglial activation is not thought to be detrimental, chronic 
microglial activation is considered to be the most damaging response of microglia to 
injury. Associations between damaged neurons and uncontrolled, hyperactivated 
microglia can result in a self-propagating positive feed-forward loop that leads to 
dysregulated and prolonged microglial activation and neuronal cell death, thus driving 
the chronic progression of neurodegeneration (Loane and Byrnes, 2010). In contrast, 
short-term microglial activation may play a beneficial role in response to injury. Since 
microglia phagocytose cellular debris and maintain cellular homeostasis, they function 
to protect and preserve healthy tissue. Additionally, in response to injury microglia 
release neuroprotective agents that promote neuronal survival or regeneration such as 
anti-inflammatory cytokines and neurotrophic factors, including nerve growth factor 
(NGF), TGF-", IL-10, and IL-1 receptor antagonist (IL-1ra) (Hailer, 2008). 
Astrocytes, the predominant cell type in the human brain, may also influence 
neuronal survival and functional outcome after TBI (Laird et al., 2008). In the uninjured 
brain, astrocytes carry out several duties that are essential for neuronal function and 
survival, including homeostatic maintenance of extracellular ionic environment and pH, 
clearance of extracellular glutamate, production of pro- and anti-inflammatory cytokines 
and chemokines, production of growth factors, and free radical release and scavenging 
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(Myer et al., 2006; Sofroniew, 2005). Astrocytes become “reactive” in response to all 
CNS insults (Sofroniew, 2005). It is not known how reactive astrocytes affect the 
progression of the injury response or overall outcome after TBI (Myer et al., 2006). As 
with microglia, both beneficial and detrimental effects have been associated with 
reactive astrocytes. Recent studies suggest that astrocytes may limit brain injury via 
their role in regulation of homeostasis. However, other work indicates that reactive 
astrocytes may contribute to increased neuroinflammation, the development of cerebral 
edema, and increased ICP, thereby exacerbating secondary injury following TBI (Laird 
et al., 2008). For example, a protective role may be provided by free radical scavenging 
or neurotrophin release, while a harmful effect may be caused by free radical release or 
pro-inflammatory cytokine production (Myer et al., 2006). 
With edema formation and swelling, activation of resident immune cells, and 
cerebral infiltration by immunocompetent cells, the post-traumatic brain shows the 
hallmark signs of inflammation (Lenzlinger et al., 2001). The previous belief that 
inflammation in TBI exacerbates cell death has been challenged by numerous reports 
demonstrating that inhibition of the inflammatory response can actually increase cell 
death and secondary tissue damage. It now appears that the most crucial element of 
anti-inflammatory intervention is the timing of its administration. While pro-inflammatory 
cytokines such as IL-1, IL-6, and TNF-# can all induce secondary tissue damage initially 
after TBI, they may well do the opposite at later stages. Although no clear mechanism 
for this has been presented, studies from non-CNS tissue damage indicate that the 
initial inflammatory response induces anti-inflammatory and wound healing factors such 
as IL-4, TGF-", and IL-10 at later stages (Cederberg and Siesjö, 2009).  
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TBI-INDUCED CELL PROLIFERATION AND NEUROGENESIS 
The scientific community had previously thought that recovery from TBI was 
severely limited due to the inability of the adult brain to replenish damaged neurons 
(Ming and Song, 2005). However, several studies in the last decade indicate that the 
mammalian CNS does have the potential to replace damaged neurons via neural 
stem/progenitor cell (NSC/NPC) proliferation (Chirumamilla et al., 2002; Rice et al., 
2003). These stem and progenitor cells are present in both the developing mammalian 
nervous system and in the adult nervous system (Song et al., 2002). NSC/NPCs 
produce neurons and glial cells well into childhood and maintain cell replacement and 
addition throughout adulthood, albeit to a lesser extent (Emery et al., 2005; Dash et al., 
2001; Jin et al., 2001). Glial progenitor cells are abundant and allow for continuous 
production of glia throughout the brain (Carpentier and Palmer, 2009). However, 
production of new neurons is restricted to two regions in the adult brain: the 
subventricular zone (SVZ) and the subgranular zone (SGZ) of the dentate gyrus of the 
hippocampus (Lois and Alvarez-Buylla, 1993). NSC/NPCs in the SVZ migrate down the 
rostral migratory pathway and replace olfactory neurons in the olfactory bulb (Rice et al., 
2003). In the SGZ, these cells migrate into the hippocampal dentate gyrus (DG) and 
differentiate into granular cell layer (GCL) neurons that are involved in networks that 
modulate mood as well as short-term learning and memory (Carpentier and Palmer, 
2009).  
In the normal hippocampus, new neurons are continually generated and migrate 
laterally from the hilus and SGZ into the GCL and eventually assume the nuclear and 
cytoplasmic morphology of surrounding granule neurons (Emery et al., 2005; Cameron 
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et al., 1993). Although many of these cells undergo apoptosis, those that survive can 
integrate into the hippocampal circuitry by extending their axonal projections into the 
CA3 region, the normal granule cell target area (Sun et al., 2007; Cameron and McKay, 
2001). It has been reported that newly generated neurons in the SGZ and mature 
granule neurons share the same neurophysiological characteristics, even when they are 
born after an ischemic insult (van Praag et al., 2002; Song et al., 2002).  
The hippocampus, a region responsible for memory and learning, is particularly 
vulnerable to insults (Dash et al., 2001). Learning, memory, and cognitive deficits are 
the hallmarks of brain trauma (Witgen et al., 2005). These deficits are observed early on 
as a result of mild to moderate TBI, but spontaneously recover with time (Schmidt et al., 
1999). This limited capacity of the brain to restore itself naturally after injury suggests 
that innate repair and regeneration mechanisms exist within the brain (Sun et al., 2005). 
Aside from activation of microglia and astrocytes and the proliferation of cells at the site 
of injury, the adult CNS has an additional response to injury that may have functional 
significance and serve as an endogenous source for repair of the injured brain 
(Chirumamilla et al., 2002; Rice et al., 2003).  
Previous studies from our laboratory and others have shown a significant 
increase in cell proliferation in the hippocampal DG in both injured juvenile and adult 
rats after LFPI (Sun et al., 2005; Rice et al., 2003; Chirumamilla et al., 2002; Dash et al., 
2001). In particular, a study in our laboratory demonstrated that TBI generated a four-
fold increase in cell proliferation in the SGZ in injured juvenile rats and a three-fold 
increase in injured adult rats compared to age-matched shams, with TBI-induced 
proliferation reaching a peak at 2 days post-injury before returning to basal levels by 14 
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days post injury (Sun et al., 2005)(Figure 1-1, Sun, 2007). In the CCI model, increased 
proliferation has also been observed in the DG that peaks at 3 days post-injury and 
stays elevated at 60 days post-injury (Rice et al., 2003).  
Several studies have been conducted to determine the composition of the 
proliferative response in the neurogenic region of the DG in the juvenile and adult 
brains. Results from our laboratory have shown that the percentage of newly generated 
cells that differentiate into neurons in the SGZ was approximately two times higher in 
juveniles than in adults at 7, 14, and 28 days post-injury. In contrast, significantly more 
cells express astrocytic marker in adults compared to juveniles post-injury (Sun et al., 
2005). Our lab later examined the maturational fate of these newly generated cells 10 
weeks after TBI and reported that the majority of the new cells that persisted in the DG 
for this period of time differentiated into mature neurons (Figure 1-2). All of these cells 
also exhibited positive immunostaining for calbindin, a protein present in all granule 
neurons in the DG. Additionally, some of these surviving granule neurons have been 
reported to extend axonal projections to the CA3 region as early as 14 days post-TBI 
(Emery et al., 2005). Furthermore, these cells establish synaptic connections with 
existing cells within the hippocampus, as determined with synaptophysin 
immunoflourescent staining (Figure 1-3; Sun et al., 2007).  
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Figure 1-1. Cell proliferation in the ipsilateral dentate gyrus in juvenile 
and adult rats following TBI. Coronal sections taken from injured juvenile 
(a) and adult (b) rats 2 days post- injury showing an elevated level of cell 
proliferation as labeled with BrdU in the DG of injured juvenile and adult rats. 
Arrows indicated BrdU-positive cells are clustered and concentrated in the 
subgranular zone (SGZ) of the DG. (c) Quantification of BrdU-positive cells in 
the SGZ. Graph shows that cell proliferation was significantly enhanced in 
injured juvenile and adult rats at both 2 and 7 days post injury as compared to 
age-matched sham controls (* p<0.05, ** p<0.01). The total number of 
proliferating cells in injured juveniles was significantly higher than injured 
adult rats at 2 days post injury (*p<0.05, n = 4/group). (d) Nissl stained 
sections cross the hippocampal dentate gyrus with red box showing the 
corresponding area in (a) and (b) (Sun et al., 2005). In addition, our lab has 
demonstrated that new granule neurons generated following TBI can establish 
the correct anatomical connections to the CA3 region (Fig. 1.3). To further 
illustrate that these new neurons integrate into the existing neuronal circuitry, 
using synaptic vesicle marker synaptophysin we have shown that newly 
generated granule neurons form synapses with existing hippocampal neurons 
(Fig. 1.4; Sun et al., 2007). 
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Figure 1-2. Newly generated cells display markers for mature granule 
cells.  (a) Confocal micrograph showing newly generated BrdU+ cells within 
the granule cell layer (green) at ten weeks post injury.  In (b) the same cells 
are labeled with the mature neuronal marker, NeuN (blue).  (c) Granule 
neurons retrograde incorporated with FG (red).   (d) Merged image of A, B 
and C.  Arrow points to one of the newly generated cells labeled with BrdU, 
NeuN and FG while the arrow head points to a cell labeled with BrdU and 
NeuN only.  Scale bar: 30$m.   (e-h) Confocal photomicrograph showing 
newly generated cells express the granule cell marker, calbindin.  The arrow 
indicates a BrdU-labeled cell (green, E) which expressed calbindin (blue, f) 
and was retrogradely incorporated with FG (red, G).  (H) Merged image of E, 
F, and G.  Scale bar: 30$m.  
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Figure 1-3. Newly generated granule neurons are retrogradely labeled 
with FG and express synaptophysin.  Confocal micrograph throughout the 
z-axis showing (a) a newly generated BrdU+ cell (green) that is retrogradely 
incorporated with FG (red) at ten weeks after its generation.  (b) The same 
BrdU-labeled cell is surrounded by a latticework of synaptophysin staining 
(blue).  (c) Merged image of (a) and (b). Scale bar: 30$m.  
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FUNCTION OF HIPPOCAMPAL NEUROGENESIS 
The function of newly generated neurons in the adult brain still remains unclear, 
but recent evidence indicates that hippocampal neurogenesis has a critical functional 
role in the normal adult brain, particularly in learning, long-term spatial memory, and 
mood (Rao et al., 2006). It has been demonstrated that the mammalian hippocampus 
regulates adult neurogenesis in an activity-dependent manner (Gould et al., 1999). 
Additionally, increasing evidence has shown that neurogenesis in the adult 
hippocampus may contribute to learning and memory functions (Sun et al., 2007). For 
example, it has been demonstrated that living in an enriched environment induces a 
robust increase in adult neurogenesis and enhanced survival of new neurons, and this 
neurogenesis was paralleled by improved performance on a hippocampal-dependent 
learning task. (Kempermann, 2002; van Praag, 1999). Evidence shows that physical 
activity also increases adult hippocampal neurogenesis and is associated with improved 
cognitive function and enhancement in spatial learning and long-term potentiation (van 
Praag, 1999). Shors et al (2001) demonstrated that performance in a hippocampal-
dependent learning task was dependent on the replication of NSCs, indicating that adult 
hippocampal neurogenesis has a role in learning and memory (Shors et al., 2001). It 
appears that the association between neurogenesis in the adult hippocampus and 
learning may be bidirectional, as one study showed that training in hippocampal-
dependent learning tasks enhanced the number of new granule cells and rescued new 
granule cells from death (Kempermann, 2002; Gould et al., 2000). In contrast, 
significant hippocampal cell loss after brain trauma has been associated with deficits in 
memory function that are directly related to injury severity (Smith et al., 1991). 
Additionally, diminished hippocampal neurogenesis, as observed following the 
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administration of anti-mitotic drugs, irradiation or genetic ablation, was associated with 
worse performance on hippocampus-dependent trace eyeblink conditioning (Shors et 
al., 2001), contextual fear conditioning (Shors et al., 2002) and long term spatial 
memory function tests (Rola et al., 2004; Jessberger et al., 2009). Collectively, these 
studies support a strong association between normal adult hippocampal neurogenesis 
and hippocampal function.  
Despite the connection between neurogenesis and cognitive function, the 
underlying mechanisms contributing to endogenous repair and regeneration following 
TBI are not fully understood. In the injured brain, increased levels of proliferation of 
granule cell precursors may be initiated by the death of mature hippocampal granule 
neurons (Jin et al., 2001). Neuronal loss and dysfunction are thought to be the 
underlying causes of behavior and cognitive deficits observed following TBI. Both 
necrotic and apoptotic cell loss have been reported in the CA1, CA3, hilus, and dentate 
gyrus regions of the hippocampus. (Dash et al., 2001). However, in both clinical and 
experimental TBI studies, hippocampal-dependent learning and memory deficits often 
diminish over time after injury (Sun et al., 2007). Together, these observations suggest 
that innate mechanisms for repair and regeneration exist within the brain. The existence 
of NSC/NPCs in the adult hippocampal DG throughout life and their enhanced levels of 
proliferation in response to brain injury has led our lab to hypothesize that neurogenesis 
may contribute to cognitive recovery after TBI. Furthermore, our laboratory has 
observed that the time frame in which injury-induced newly generated cells differentiate 
into mature granule neurons and integrate into existing hippocampal circuitry is 
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coincident with the time course of spontaneous cognitive recovery as determined by 
Morris Water Maze data following injury (Figure 1-4, Sun et al., 2007).  
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Figure 1-4. Cognitive deficits following TBI recover over time.  Graph 
comparing Morris water maze performance of injured rats to sham animals 
during trials at days 11-15, 26-30 or days 56-60 following injury.  Injured 
animals displayed significant cognitive deficits, as characterized by a longer 
latency, at 11-15 days post injury when compared to sham animals (*p<0.05).  
These deficits persisted at 26-30 days (*p<0.05).  At days 56-60, injured 
animals showed cognitive recovery with a shorter latency which was not 
significantly different to sham animals (Sun et al., 2007). 
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TBI AND THE AGING BRAIN 
Age is one of the most reliable and important predictors of morbidity and mortality 
following TBI (Senathi-Raja et al., 2010). It is well known that juveniles exhibit greater 
functional recovery than adult patients following TBI. Himanen et al. (2006) found that 
higher age at injury (especially over 60 years of age) was a significant risk factor for 
cognitive decline, while younger age at injury was associated with cognitive 
improvement in a 30-year follow-up study (Himanen et al., 2006). After the age of 12, 
there is a progressive increase in mortality and long-term morbidity after injury. For 
example, elderly patients are twice as likely as younger patients to remain severely 
disabled or vegetative after moderate TBI (Hamm et al., 1992). The age-associated 
increases in morbidity and mortality following TBI can be observed in rodents. Hamm et 
al. (1992) has shown that aged rats (20 months) were more than twice as likely to die 
after fluid percussion TBI than young adult rats (3 months). It was also shown that when 
young adult and aged rats are subjected to injury of the same severity, the aged 
animals experience more severe impairment of both motor and cognitive function as 
assessed by beam-walking and MWM performance. These greater cognitive and motor 
deficits observed in aged rats are consistent with human clinical TBI (Hamm et al., 
1992).  
The exact mechanisms underlying this age-related increase in vulnerability to TBI 
are unknown.  In the normal brain, there is a progressive decline in function with 
increasing age (Lazarov et al., 2010). The normal aging hippocampus undergoes many 
degenerative changes both morphologically and functionally that may contribute to 
memory and learning deficits associated with older populations (Kuhn et al., 1996; 
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Driscoll et al., 2006). Importantly, granule cells in the DG continue to be generated 
throughout adulthood, but there is an 80% decline in NSC proliferation and 
neurogenesis in the normal aged brain across several species (Seki and Arai, 1995; 
Olariu et al., 2007; Galvan and Jin, 2007; Kuhn et al., 1996; Rao et al., 2006). However, 
despite the reduced hippocampal neurogenesis associated with aging, the neurons that 
are newly generated appear functionally equivalent to those in the young brain, 
suggesting that neurogenesis in the aged brain is downregulated as opposed to 
abberant (Lazarov et al., 2010). 
Advancing age is accompanied by a decrease in the volume of the hippocampal 
formation thought to be due to shrinking neuronal size, reduced neuronal and synaptic 
density, decreased plasticity, and decreasing neurotransmitter levels (Senathi-Raja et 
al., 2010; Driscoll et al., 2006; Brazel and Rao, 2004). Additionally, it has been observed 
that aged rats with spatial memory impairments exhibit lower levels of dentate gyrus 
neurogenesis than aged rats with preserved spatial memory (Rao et al., 2006). Thus, 
reduced hippocampal neurogenesis appears to be related to both structural and 
functional deficits of the hippocampus associated with aging (Driscoll et al., 2006; 
Lazarov et al., 2010). Cellular changes in the aged brain such as increased oxidative 
stress and damage to DNA and proteins may also contribute to cognitive decline (Brazel 
and Rao, 2004). 
It has been suggested that the brain may use the same mechanisms for 
adaptation to aging that it does for recovery, and thus has a finite capacity for plasticity. 
It appears that collective effects of TBI and aging may have a synergistic adverse effect 
on cognitive outcome following injury, which may be in part due to the limited capacity of 
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the aged brain to compensate during initial recovery (Senathi-Raja et al., 2010). The 
aged brain demonstrates gene expression profiles representative of microglial activation 
and neuroinflammation. Additionally, there is evidence that microglia in aged animals 
exhibit an amplified inflammatory response when stimulated (Cekic and Stein, 2010; 
Loane and Byrnes, 2010). Our laboratory conducted a study to measure the glial 
response in injured young adult and aged brains at 28 days post-injury. The 20 month 
old injured rat had slightly higher levels of GFAP, and significantly higher levels of ED1 
and Iba1 than the 3 month old injured rat, suggesting that the aged animals have an 
increased inflammatory response relative to the younger rats (Figure 1-5; unpublished 
data from Sun, 2011). The neurological dysfunction observed in aged animals may be in 
part due to this neuroinflammatory priming. We posit that enhanced microglial sensitivity 
to immune activation does not resolve in the environment within the aged brain, which 
may exacerbate secondary injury resulting in both a severe immune response as well 
as immune factor release from damaged cells within the brain (Cekic and Stein, 2010).  
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Figure 1-5. Level of glial response in the injured brain at 28 days post-
injury. (a) and (b) In the ipsilateral GCL and hilus, the injured 20M old rat had 
slightly higher percentage of GFAP expression than the 3M old rat, but not 
statistically significant. (c) and (d) The injured 20M old had a significantly 
higher percentage of ED1 expression in the ipsialteral GCL and hilus regions 
than the 3M old counterpart. (e) and (f) The injured 20M old had significantly 
higher expression of Iba1 in both the GCL and hilus regions than the injured 
3M old (Sun et al., unpublished data). 
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NEUROINFLAMMATION AND NEUROGENESIS 
 The inflammatory response to injury can produce both detrimental and beneficial 
conditions for neurogenesis, as it imposes varying effects on neural progenitor cell 
(NPC) proliferation, migration, differentiation, survival, and incorporation of newly born 
neurons into the existing hippocampal circuitry (Sierra et al., 2010; Mathieu et al., 2010). 
The profile of inflammatory mediators depends on the severity of inflammation, resulting 
in varying consequences on neurogenesis. CNS inflammation ranges from mild acute to 
uncontrolled chronic inflammation (Lucas et al., 2006; Whitney et al., 2009). During mild 
acute inflammation, inflammatory mediators tend to promote neurogenesis, but 
uncontrolled inflammation produces an environment that opposes neurogenesis (Sierra 
et al., 2010; Pluchino et al., 2008). Additionally, the pro- and anti-neurogenic effects of 
inflammation may also depend on the type and duration of microglial and/or astrocytic 
activation (Das and Basu, 2008). An understanding of the potential effects of 
inflammation on neurogenesis may potentially help identify therapeutic strategies for 
treatment of neuronal injury (Whitney et al., 2009). 
Independent studies have shown that microglial cell activation induced by an 
LPS challenge in the brain is associated with a reduction in hippocampal neurogenesis 
(Jakubs et al., 2008; Ekdahl, 2012). Additionally, hippocampal neurogenesis can be 
restored by anti-inflammatory drug administration. These studies reported a negative 
association between the number of activated microglia and the number of newly 
generated neurons (Mathieu et al., 2010). Pro-inflammatory cytokines such as IL-1, IL-
6, and TNF-# are released by activated microglia and are thought to mediate the 
relationship between microglia and neurogenesis. Microglial activation may also 
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negatively regulate different steps of neurogenesis via release of prostaglandins 
(Ekdahl, 2012).  
TNF-# is primarily released by activated microglia and plays a role in several 
neurodegenerative disorders. Based on the model and methods of injury, TNF-# can 
display both pro- and anti-neurogenic effects. Lipopolysaccharide (LPS)- activated 
microglia have been reported to inhibit neuronal differentiation via TNF-# expression. 
When a TNF-# inhibitor was administered, neuronal differentiation was partially 
restored, indicating that it has an anti-neurogenic effect when combined with LPS-
conditioned media. Furthermore, other data suggests that TNF-# released from 
microglia may contribute to death of hippocampal NPCs after injury (Whitney et al., 
2009). Activated microglia may also suppress neurogenesis via production of IL-6. One 
study reported that chronic production of IL-6 in a transgenic mouse model resulted in 
dramatically reduced hippocampal neurogenesis via reduction of NPC proliferation, 
survival, and differentiation (Whitney et al., 2009). Mathieu et al. studied the effects of 
chronic expression of IL-1" and observed a 50% reduction in the percentage of injury-
induced proliferating cells that differentiated into neurons (Mathieu et al., 2010). 
In contrast, the anti-inflammatory cascade is thought to promote neurogenesis, 
as administration of anti-inflammatory cytokine TGF-" has been reported to support 
neurogenesis (Ekdahl, 2012). However, in the aged brain, chronically activated 
microglia induce a prolonged and amplified neuroinflammatory response (Cekic and 
Stein, 2010). Ongoing inflammation in the CNS is associated with many 
neurodegenerative disorders, and is known to play a role in neuronal death observed in 
Alzheimer’s and Parkinson’s diseases (Ekdahl et al., 2003). Further, studies support 
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that persistent inflammation may contribute to the memory loss in these disorders by 
disrupting formation of new neurons (Das and Basu, 2008). The exaggerated 
neuroinflammation in the aged brain results in reduced plasticity during recovery, 
continued release of oxidative stressors, and enhanced production of inflammatory 
cytokines such as TNF#, IL-1", and IL-6. In situations of chronic microglial activation, 
these cytokines disrupt long-term potentiation, memory consolidation, neurite outgrowth, 
and hippocampal neurogenesis (Cekic and Stein, 2010). 
As discussed in the previous section, following TBI, there is a full range of 
inflammatory cell responses including infiltration of macrophages and activation of 
microglia and astrocytes accompanied with production of inflammatory cytokines.  Our 
laboratory has recently observed that following TBI, the aged brain retains cell 
proliferative capacity; however, this injury-induced proliferative response predominantly 
generates microglial cells.  Moreover, new neurons generated in the aged brain failed to 
survive for an extended period. These findings lead us to explore the hypotheses that 
heightened levels of injury-induced inflammation in the aged brain may play a pivotal 
role influencing neurogenesis and cognitive function, and that inhibition of this injury-
induced inflammatory response may restore hippocampal neurogenic response and 
ultimately improve cognitive function of the injured aged animals. 
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MINOCYCLINE AS A POTENTIAL THERAPY 
 Inflammation is a key component in the pathological environment following TBI, 
and several components of this response have been identified as targets for therapeutic 
intervention (Helmy et al., 2011). Potential inflammatory targets have included microglial 
activation, leukocyte extravasation via adhesion molecules or matrix metalloproteinases 
(MMPs), IL-1, TNF-#, and NO, among several others (Lucas et al., 2006). Minocycline, 
a tetracycline antibiotic, has multiple targets and exhibits anti-inflammatory and 
neuroprotective properties that have been demonstrated in many models of brain injury 
(Hewlett and Corbett, 2006) . Minocycline reduces cytokine expression via inhibition of 
microglial activation and inhibits MMP and the inducible form of nitric oxide synthase 
(iNOS) actions (Yrjanheikki, 1999; Lucas et al., 2006). It also downregulates caspase-1, 
which contributes to its anti-apoptotic properties. Minocycline has been used extensively 
in humans for treatment of both chronic and acute conditions, including acne, 
staphylococcal infections, and rheumatoid arthritis (Sanchez Mejia et al., 2001).  
 Minocycline is able to cross the BBB and inhibit microglial activation in 
neurodegenerative disease models (Ekdahl et al., 2003). Most studies that have 
reported neuroprotective effects of minocycline in rodents following brain injury have 
used doses of 10-90 mg/kg administered intraperitoneally. Minocycline reaches peak 
concentration in systemic circulation at 2.5 hours after intraperitoneal injection and has 
a half-life of 3 hours in rats (Elewa et al., 2006). In a study examining the effects of LPS-
induced microglia in a status epilepticus (SE) model, administration of minocycline 
during a 5 week period after SE resulted in enhanced neurogenesis and a decrease in 
the microglial population (Ekdahl et al., 2009), but minocycline did not affect 
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neurogenesis in control animals (Ekdahl et al., 2003). Similarly, minocycline has been 
shown to reduce functional impairment resulting from cerebral focal ischemia, and this 
improvement is associated with decreased microglial activation and enhanced 
hippocampal neurogenesis in addition to an improved neural environment after chronic 
treatment (Liu et al., 2007). In another study, intraperitoneal administration of 
minocycline 12 hours before or 30 minutes after TBI resulted in improved neurological 
function compared to controls injected with saline (Sanchez Mejia et al., 2001).  
Collectively, these studies suggest that modulation of microglia activation by 
minocycline can enhance hippocampal neurogenesis.  In this study, we will explore the 
efficacy of anti-inflammatory treatment with minocycline as a potential therapy to restore 
hippocampal neurogenesis and cognitive function following TBI. We administered 
minocycline to both young adult and aged rats to begin to explore whether 
inflammation-mediated reduction of hippocampal neurogenesis can be reversed by 
inhibition of microglial activation, especially in the aged brain where microglia exhibit an 
amplified response.  
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CHAPTER 2 – METHODS AND MATERIALS 
SUBJECTS 
 Male Fisher 344 rats aged at 3 months and 20 months (NIA) were used for this 
study. The 3 month-old rats weighed approximately 300 grams and were housed in 
pairs. The 20 month-old rats weighed approximately 450 grams and were housed 
individually. Both groups were housed in a facility that maintained a temperature of 20-
22 degrees Celsius with a 12-hour light/dark cycle and with food and water available ad 
libitum. Of the twenty-four young rats employed for this study, 16 were used to examine 
minocycline treatment on injury-induced cell proliferation and generation of new neurons 
at the early time post-injury. Of the seventeen aged rats employed for this study, 16 
were used to study these effects. The remaining rats died immediately following injury 
or within the first week following injury. The mortality rate for 3 month-old rats was 10% 
following CCI injury and 43.8% following LFPI injury. The mortality rate for 20 month-old 
rats was 0% following CCI injury and 30.8% following LFPI injury. All protocols and 
animals used for this study complied with NIH guidelines and were approved by the 
Institutional Animal Care and Use Committee at Virginia Commonwealth University.  
SURGICAL PREPARATION AND PROCEDURE 
 Seven aged and seven young rats were subjected to a moderate lateral fluid 
percussion injury (LFPI), and nine aged and nine young rats were subjected to a 
moderate controlled cortical impact (CCI) injury following standard protocols. All tools 
used for the surgical procedure were sterilized in an autoclave, and an aseptic 
environment was prepared for the surgical procedures. The rats undergoing FPI were 
 37 
anesthetized with 5% isofluorane in a Plexiglas chamber, intubated, and ventilated with 
2.5% isofluorane in a gas mixture (30% oxygen, 70% nitrogen). The rats undergoing 
CCI injury were anesthetized with 5% isofluorane in a Plexiglas chamber, and were 
ventilated through a nose cone with 2.5% isofluorane in a gas mixture (30% O2, 70% 
N2) throughout the surgery. After shaving the scalp, the animal was secured in a 
stereotaxic frame. To disinfect the site of incision, betadine was applied to the shaved 
region of the head. Puralube ointment was placed in the eyes to prevent dryness during 
the procedure. To expose the skull, an incision was made along the midline and the 
surrounding connective tissue was pulled back and clamped with hemostats. A 4.9 mm 
craniotomy was made on the left parietal bone midway between lambda and bregma 
using a trephine and a Dremel drill with a small drill bit. The bone chip over the 
craniotomy site was detached and any remaining bone fragments along the edges of 
the craniotomy were carefully removed. 
LATERAL FLUID PERCUSSION INJURY (L-FPI) 
 Once the craniotomy site was cleaned, a Luer lock fitting was placed over the 
craniotomy and cemented in place with a dental acrylic mixture. When the acrylic had 
dried, the fitting was filled with saline solution in order to ensure that it was completely 
sealed and to provide a continuous medium though which the injury would be applied. 
At this time, the rat was removed from isofluorane anesthesia until it regained 
consciousness as assessed by demonstration of paw and tail reflexes. The fluid 
percussion injury device (Figure 2-1) was calibrated by performing pressure 
measurements every 30 seconds until the animal regained consciousness in order to 
ensure that the device would produce an injury level within the target pressure range of 
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1.77 ± 0.05 atm. The intubation tube was disconnected, the rat was removed from the 
stereotaxic frame, and was then transferred and connected to the injury device via the 
Luer lock fitting. A moderate fluid impulse of 1.77 ± 0.05 atm was applied. Once the 
injury was administered, the animal was taken back to the surgery bench where the 
fitting was removed from the skull. The rat was reconnected to ventilation without 
isofluorane and placed in a supine position with gauze underneath the open incision. 
Paw and tail reflexes and righting time were recorded during the recovery period in 
order to assess the injury severity and verify that all animals received a comparable 
injury. The rat’s righting time is the amount of time that passed from the point of injury 
until the rat spontaneously returns to an upright position. Once this occurred, the 
animals were again placed under anesthesia with 2.5% isofluorane and the incision was 
sealed using 5-0 surgical suture with a sterile stainless steel suture needle. A triple 
antibiotic ointment and 2% lidocaine hydrochloride jelly were applied to the sutured 
region. A surgical drape was placed inside the cage and the rat was transferred back to 
the cage, which was situated on a heating pad to aid the recovery process.  
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Figure 2-1. Fluid percussion injury device. A photograph of the injury 
device used to deliver lateral fluid percussion injury (LFPI) to young and aged 
rats. 
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CONTROLLED CORTICAL IMPACT (CCI) INJURY 
Once the craniotomy site was cleaned, the rat was removed from isofluorane 
anesthesia and transferred to the CCI injury device (Figure 2-2). To prepare the injury 
device, the 3 mm steel impactor tip was carefully adjusted to a location perpendicular to 
the surface of the brain just over the craniotomy so that the dura would not be pierced 
upon delivery of the injury. Once the rat demonstrated a tail reflex, a moderate injury 
corresponding to a 2.3 mm depression of the dura was delivered with a velocity of 4 m/s 
and a dwell time of 0.05 seconds. After the injury was delivered, the incision was 
sutured and the animal was allowed to recover following the same procedure as 
described for the FPI injury. The time to regain paw and tail reflexes and righting time 
were recorded as previously described, and once normal breathing was observed the 
animal was transferred to its cage with a surgical drape placed inside and with the cage 
over a heating pad. Sham animals underwent the same surgical procedure without 
injury delivery.  
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Figure 2-2. Controlled cortical impact injury device. A photograph of the injury 
device used to deliver controlled cortical impact injury (CCI) to young and aged rats. 
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MINOCYCLINE AND BRDU INJECTIONS 
Minocycline is a tetracycline antibiotic that exhibits anti-inflammatory and anti-
apoptotic properties that have been demonstrated in many models of brain injury 
(Hewlett and Corbett, 2006). Minocycline (Sigma) was administered intraperitoneally 
(i.p.) to the 3 month-old and 20 month-old rats that underwent FPI and CCI injuries. 
These animals were divided into two different minocycline treatment groups, group 1 
and group 2 (Table 2-1). Of the seven aged rats subjected to FPI, four were assigned to 
group 1 and three were assigned to group 2. Of the seven young rats subjected to FPI, 
three were assigned to group 1 and four were assigned to group 2. Nine young and nine 
aged rats received CCI injuries. In both age groups, three animals were vehicles, three 
were assigned to group 1, and three were assigned to group 2.  
Minocycline was dissolved in sterile saline at a 15 mg/ml concentration before 
boiling point with neutral pH maintained. In treatment group 1, animals received a first 
i.p. injection of minocycline at the dose of 45 mg/kg at 30 minutes post-TBI, followed by 
a second dose of 45 mg/kg at 8 hours post-TBI.  In treatment group 2, animals received 
the first 45 mg/kg dose at 4 hours post-TBI, followed by a second dose at 8 hours post-
TBI.  On the first and second days post-injury, both groups received minocycline i.p. 
injections twice daily at a dose of 22.5 mg/kg with 12 hours in between.  Vehicle 
treatment animals received equal volume of sterile saline injection.  
To label cell proliferation, 5-bromo-2’-deoxyuridine (BrdU, Sigma), a thymidine 
analog that can be incorporated into the newly synthesized DNA of replicating cells, was 
used.  All animals received 4 doses of i.p. BrdU injection (50mg/kg, two hrs in between 
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each injection) at two days post-injury.  All animals in the study were sacrificed at 3 
days following TBI (24 hrs after the last BrdU/minocycline injection).  
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Table 2-1. Animal treatment groups in minocycline study. Table showing the 
number of animals in each group in the minocycline study based on injury model, 
age, and treatment group.  
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 LFPI CCI 
 Young (3M) Aged (20M) Young (3M) Aged (20M) 
Sham 3 3 3 3 
TBI+veh 4 4 3 3 
Mino group 1 (30 min, 8 hr) 3 4 3 3 
Mino group 2 (4 hr, 8 hr) 4 3 3 3 
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TISSUE PROCESSING 
 Animals were sacrificed at 3 days post-injury. After deep anesthetization with 
isofluorane until complete cessation of breathing, the rats were transcardially perfused 
with 400 ml of 1x phosphate buffer solution (PBS) followed by 400 ml of 4% 
paraformaldehyde in PBS. The skulls were then opened and the brains were removed 
and post-fixed in 4% paraformaldehyde in PBS for a minimum of 48 hours at 4°C.  
 After 48 hours of post-fixation, the brains were placed in PBS. A Leica vibratome 
was used to slice each brain into 60 µm thick coronal sections throughout the rostro-
caudal extent of the brain. Four groups of 30 serial coronal sections were collected from 
each brain, and the sliced tissue sections were collected into five 24-well plates filled 
with PBS + 0.01% sodium azide and were stored in a refridgerator kept at 4°C until 
needed for staining procedures. 
IMMUNOHISTOCHEMISTRY 
 One set of 30 sections from each brain used in the study was stained for BrdU 
immunohistochemistry to determine the number of newly proliferating cells in the DG 
after injury. Another set of 30 sections from every brain used in the study was 
processed for doublecortin (DCX), a microtubule-associated protein expressed by 
immature neurons, to assess the number of newly generated neurons after injury. 
 BRDU IMMUNOSTAINING 
 Selected sections were first washed twice with PBS for 5 minutes and then 
denatured in 50% formamide for 1 hour at 65°C. The sections were washed with 2x 
saline sodium citrate (SSC) 2 times for 5 minutes, and then 2N HCl was placed on the 
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sections for 30 minutes at 37°C. The sections were rinsed with PBS 2 times for 5 
minutes, and quenched with 3% hydrogen peroxide for 1 hour on a shaker. The 
sections were rinsed with PBS + 0.3% Triton100 for 10 minutes on the shaker before 
adding a blocking buffer consisting of 5% normal horse serum in PBS + 0.3% Triton. 
The sections were blocked overnight at 4°C on a shaker, and then incubated with the 
primary antibody solution for 48 hours at 4°C on a shaker. The primary antibody solution 
consisted of mouse anti-BrdU antibody (Dako, CA) at a 1:200 dilution in the blocking 
buffer, and 300 µl was added to each well. Following 48 hour incubation, the sections 
were brought back to room temperature and rinsed in PBS + 0.3% Triton100 for 10 
minutes 3 times. The sections were then blocked in the blocking buffer solution for 3 
hours at room temperature before they were incubated with the secondary antibody 
solution at 4°C overnight on a shaker. The secondary antibody solution consisted of 
biotinylated anti-mouse IgG (Jackson Laboratories, ME) at a 1:200 dilution in blocking 
buffer, and 300 µl was added to each well. After overnight incubation, the sections were 
brought back to room temperature and washed with 1x PBS for 10 minutes 3 times. The 
avidin-biotin complex (ABC kit, Vector Laboratories) was prepared 30 minutes before 
use at a concentration of 1:200 avidin and 1:200 biotin in 1x PBS. The sections were 
incubated with ABC for 2 hours at room temperature on a shaker, and then washed with 
1x PBS for 10 minutes 3 times. The liquid DAB solution was prepared using a Vector 
DAB kit by adding 2 drops of phosphate buffer at a pH of 7.5, 4 drops of 3,3’-
Diaminobenzidine, and 2 drops of hydrogen peroxide to each 5 ml of nanopure water 
required to incubate each section with 300 µl of DAB. The sections were incubated with 
the DAB solution and the reaction was monitored under a microscope until the sections 
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were adequately stained, and then quenched with 1x PBS to stop the reaction. The 
sections were washed with 1x PBS for 5 minutes 3 times and stored in a refrigerator at 
4°C. The sections were washed in distilled water and mounted to glass microscope 
slides, with 6 sequential sections per slide.  
DCX IMMUNOSTAINING 
 The sections were washed with 1x PBS for 5 minutes 2 times and then quenched 
with 3% hydrogen peroxide 1 hour. They were then washed with PBS + 0.3% Triton100 
for 5 minutes 3 times before incubation with the blocking buffer solution (5% normal 
horse serum in 1x PBS + 0.3%Triton100) for 3 hours at room temperature on a shaker. 
The sections were then incubated with a goat anti-rat DCX antibody (Santa Cruz, CA) 
solution at a dilution of 1:1000 in blocking buffer for 48 hours at 4°C. After incubation, 
the sections were washed with 1x PBS + 0.3% Triton100 for 10 minutes 3 times. Next, 
they were blocked in blocking buffer for at least 3 hours at room temperature prior to 
overnight incubation with biotinylated anti-goat IgG (Jackson Laboratories, ME) at a 
dilution of 1:200 in blocking buffer at 4°C. The sections were then washed with 1x PBS 
+ 0.3% Triton100 for 10 minutes 3 times and incubated with ABC for 2 hours at room 
temperature. They were then washed with PBS and incubated with DAB at room 
temperature, and the reaction was observed under a microscope. When adequately 
stained, the sections were quenched with PBS and washed 3 times with PBS. They 
were rinsed with distilled water and mounted on glass microscope slides, with 6 
sequential sections per slide.  
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COUNTERSTAINING PROCEDURE 
 Sections mounted on the glass slides were placed in distilled water and then 
stained with 0.1% cresyl violet solution for 1 minute. They were washed in running tap 
water 3 times, or until the water ran clear, and then placed back in distilled water. The 
sections were then placed in ethanol in increasing concentrations (two 75% solutions, 
one 95% solution) for approximately 1 minute each. They were placed in an acid alcohol 
solution for approximately 30 seconds or until the counterstain color was appropriate, 
and then dehydrated in 2 containers filled with 100% ethanol for 1 minute each. They 
were placed in Citrisolv twice for 5 minutes each, and cover slipped with Permount.  
STEREOLOGICAL QUANTIFICATION 
 The BrdU- and DCX-positive cells present in the DG were quantified using the 
Olympic Image CAST program (Olympus, Denmark). Of the 30 coronal sections 
obtained from each brain for each staining technique, 10 sections spanning the DG      
(-2.56 mm to -5 mm of the bregma) were selected for examination using unbiased 
stereological methods. Positively labeled cells in the ipsilateral hilus, subgranular zone 
(SGZ), and granule cell layer (GCL) were counted in each of these sections. For the 
BrdU quantification, the SGZ and GCL were counted together as the GCL. For the DCX 
quantification, the SGZ and the hilus were counted together as the hilus. Under 4x 
objective, the GCL and hilus were outlined and the cells within each region of interest 
were counted under 40x objective focusing through the thickness of each section. In the 
DCX stereological procedure, all neurons were categorized based on the vertical, 
horizontal, or mixed orientation of their dendrites. The average thickness of the DG of 
each brain was determined by measuring the depth of each section from one focal 
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plane to another in 5 randomly selected locations in the DG, and then averaging the 
thickness of all 10 sections to calculate the average thickness (t) of each brain. The 
entire region of interest in each section was examined for stereological quantification 
instead of random samples, so the average sampling fraction (asf) was equal to 1. The 
dissector height (h) was set to 15 µm. Using these parameters, the total number of cells 
in each DG was estimated as N=(%Q)(t/h)(1/asf)(1/ssf), where ssf was the section-
sampling fraction (ssf = 0.25), and %Q was the raw number of cells counted.  
STATISTICAL ANALYSIS 
 Analysis of the righting times for animals following surgery was performed using 
post-hoc student t-tests (only one-tailed t-tests were considered) to determine any 
statistically significant differences within groups. Statistical analysis of cell proliferation 
and neurogenesis data was performed using one-way ANOVA followed by post-hoc 
LSD tests to determine differences in BrdU and DCX quantification data within 
treatment groups. P-values less than 0.05 were considered statistically significant. No 
two-way ANOVA analysis was performed.  
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CHAPTER 3 - RESULTS 
 Numerous studies have suggested that inflammation plays a critical role in 
modulating neurogenesis, and that the increased inflammatory response in the aged 
brain may contribute to decreased neurogenesis and poorer cognitive recovery 
following TBI. This study aimed to determine the effects of anti-inflammatory treatment 
with minocycline on cell proliferation and neurogenesis in 3-month old young rats and 
20-month old aged rats in the acute post-traumatic period. Two different minocycline 
treatment groups were employed, with one group receiving a first minocycline dose at 
30 minutes post-TBI (treatment group 1) and the other group receiving a first dose at 4 
hours post-TBI (treatment group 2). Additionally, the effects of minocycline administered 
in these two time courses in young and aged rats were examined in two most widely 
used TBI models, namely, LFPI and CCI injury models. Micrographs showing the 
location of the LFPI and CCI injuries relative to the hippocampus are shown in Figure 3-
1. Fisher 344 rats were used for this study because it is the only strain that the aged 
rats are available. A 3-month old Fisher 344 rat represents a fully mature, young adult, 
and a 20-month old Fisher 344 rat represents a late middle-aged animal that is 
comparable to a human approximately 50 years old (Hamm et al., 1992).  
To assess whether anti-inflammation treatment with minocycline affects injury-
induced cell proliferation in the DG after LFPI and CCI, animals were injected with BrdU 
four times 2 hours apart at 2 days post injury and sacrificed 3 days post injury. Ten 
sections from each brain were stained for BrdU to label newly proliferating cells. These 
cells are typically observed in the hilus or SGZ, which are the proliferating zones of the 
hippocampal DG, and fewer newly proliferating cells are observed in the GCL. For this 
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reason, BrdU-positive cells in the GCL and SGZ were taken together as the newly 
proliferating cells in the GZ, and were counted separately from BrdU-positive cells in the 
hilus. To assess whether anti-inflammation treatment with minocycline can enhance 
hippocampal neurogenesis in the young and aged brains following LFPI and CCI injury, 
ten sections from each brain of animals sacrificed 3 days post-injury were stained for 
early neuronal marker DCX. In all animals, DCX-positive cells were primarily localized in 
the SGZ of the DG, with some additional DCX-positive cells located in the GCL. In this 
study, DCX-positive neurons in the GCL, SGZ, and hilus were all counted together as 
newly generated neurons in the DG. Newly generated DCX-positive neurons were 
classified according to three types of dendrite morphologies: vertically oriented 
dendrites (Figure 3-2a), horizontally oriented dendrites (Figure 3-2b), and mixed 
dendrites (Figure 3-2c). Neurons with horizontal and mixed dendrites were taken to be 
newly generated cells after injury, while those with vertical dendrites were taken to be 
neurons that were generated prior to injury. Expression of DCX in new neurons lasts 
about 2 weeks.  
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Figure 3-1. Location of LFPI and CCI injury. Micrographs taken from a) 3M sham 
animal, b) 20M sham animal, c) 3M vehicle-treated animal following CCI injury, d) 
20M vehicle-treated animal following CCI injury, e) 3M vehicle-treated animal 
following LFPI injury, and f) 20M vehicle-treated animal following LFPI injury. These 
images show the location of the injuries relative to the hippocampal region.  
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Figure 3-2. Characterization of DCX+ newly generated neurons. Three 
types of DCX+ cells are observed in the GCL: a) cell with vertically orientated 
soma and dendrites, b) cells with horizontally orientated soma and dendrites, 
c) cell with both horizontal and vertical dendrites (mixed dendrites). Confocal 
micrograph shows BrdU/DCX double-labeled cells which are newly generated 
DCX+ neurons at 2 days post-injury do not have vertical dendrites (Sun, 
unpublished data).  
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STUDY 1: EFFECT OF MINOCYCLINE TREATMENT IN LFPI MODEL 
MORTALITY RATE AND RIGHTING TIME FOLLOWING LFPI  
 To assess the effect of minocycline on cell proliferation and neurogenesis after 
LFPI a total of 14 young rats and 13 aged rats were used. The mortality rate in young 
rats was 43.8% and in aged rats was 30.8%. These values are similar to those that 
have been reported in other studies for young adult rats, but lower than those typically 
reported for aged rats (Reid et al., 2010; Hamm et al., 1991). Due to the high sensitivity 
of Fisher 344 rats to LFPI injury, the target injury level was slightly lowered in order to 
increase survival rates during the study. The righting response, which is the time 
required for an injured animal placed on its back to spontaneously return to an upright 
position, was recorded immediately after injury as a measure of injury severity !Hamm, 
2001). The mean ("SEM) righting time for young rats after LFPI was 12 "#2.08 minutes 
for minocycline-treated animals and 10.13 ± 1.14 minutes for vehicle-treated animals. 
Analysis of this data with a t-test indicated that there was no significant difference 
between the righting times of the vehicles compared to the rats treated with 
minocycline, indicating that a similar severity of injury was received by both groups (p = 
0.95). The mean (±SEM) righting time for aged rats after LFPI was 8.89 ± 0.93 minutes 
for minocycline-treated animals and 13.19 ± 2.17 minutes for vehicle-treated animals. 
This difference was also not statistically significant, indicating that all animals received a 
comparable injury (p = 0.07). 
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THE EFFECT OF MINOCYCLINE ON CELL PROLIFERATION IN YOUNG ADULT 
AND AGED RATS FOLLOWING LFPI 
 In 3 month-old sham animals, very few BrdU-positive cells were observed in the 
DG, but the injured vehicle animals showed a greatly enhanced number of BrdU-
positive cells (Figure 3-3). Animals treated with minocycline both 30 minutes and 4 
hours post-TBI showed a reduction in the number of BrdU-positive cells in the GZ 
following injury compared to vehicles. Stereological quantification of BrdU-positive 
proliferating cells in the GZ and hilus showed that the vehicle-treated animals had 
significantly more BrdU-positive cells compared to shams (p < 0.05 in GZ and hilus; 
Figure 3-4). There were no significant differences in the number of BrdU-positive cells in 
the GZ or hilus of animals treated with minocycline 30 minutes post-TBI or 4 hours post-
TBI compared to vehicle-treated animals. However, animals treated with minocycline in 
either treatment group tended to show a reduced level of cell proliferation in the GZ and 
hilus compared to vehicles (Figure 3-4). There was no significant difference in the 
number of BrdU-positive cells observed in the GZ or hilus between treatment groups, 
but those treated 4 hours post-TBI tended to show a slightly greater reduction of cell 
proliferation following LFPI (Figure 3-4). This data suggests that administration of 
minocycline in either treatment group tends to reduce the injury-induced cell proliferative 
response in the DG in young rats after LFPI.  
In the 20-month old rats, similar to young adult rats, very few BrdU-positive cells 
were observed in the DG.  Following injury, there was a marked increase in BrdU-
positive cells in the vehicle-treated animals (Figure 3-3). Compared to injured vehicle- 
treated animals, animals treated with minocycline starting at 30 minutes or 4 hours post-
TBI had a lower number of BrdU-positive cells. Stereological quantification of BrdU-
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positive cells in the ipsilateral DG showed a significantly higher number of cell 
proliferation in the GZ and hilus of vehicle-treated animals compared to shams (p < 0.05 
in GZ and hilus, Figure 3-5).  Following minocycline treatment, the number of BrdU-
positive cells was decreased in the GZ in both treatment groups particularly in the 4 hr 
treatment group. The number of BrdU-positive cells in the hilus was not significantly 
affected (Figure 3-5). There was no significant difference in the number of newly 
proliferating BrdU-positive cells in the GZ or hilus between the two treatment groups. 
This data suggests that minocycline treatments administered 30 minutes or 4 hours 
post-TBI tend to reduce cell proliferation after LFPI in aged rats. The decrease in cell 
proliferation is more notable and trending toward significance in animals treated 4 hours 
post-TBI.  
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Figure 3-3. Newly generated cells in the ipsilateral DG at 3 days post-injury in 
young and aged rats following LFPI. Micrographs taken from BrdU-stained coronal 
sections in the ipsilateral DG from a) 3M sham animals, b) 3M injured vehicle-treated 
animals, c) 20M sham animals, d) 20M injured vehicle-treated animals. a) In the 3-
month old sham, very few BrdU+ cells were observed in the DG. b) 3-month old 
injured vehicle animals showed a greatly enhanced number of BrdU+ cells in the GZ 
and hilus. c) Very few BrdU+ cells were observed in the DG of the 20-month old 
sham animal, but the injured vehicle showed many more BrdU+ cells in the GZ and 
hilus (d). 
 64 
 
  
 65 
 
  
Figure 3-4. Stereological quantification of cell proliferation in the 
granular zone and hilus of young rats at 3 days post injury after LFPI. a) 
In the ipsilateral GZ (GCL and SGZ), vehicle-treated injured animals had 
significantly more BrdU+ cells compared to shams (*p<0.05). Animals treated 
with minocycline 30 minutes and 4 hours post-TBI showed a reduction in the 
number of BrdU+ cells compared to vehicle-treated animals, but did not reach 
statistical significance. b) In the ipsilateral hilus, vehicle-treated animals 
showed a significant enhancement in the number of BrdU+ cells compared to 
shams (*p<0.05). Neither treatment group showed a significant difference in 
the number of BrdU+ newly proliferating cells after injury compared to 
vehicles, but the animals treated 4 hours post-TBI showed a reduction in the 
injury-induced cell proliferative response. There was no significant difference 
in the number of BrdU-positive cells between treatment groups among injured 
animals in the GZ or hilus. 
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Figure 3-5. Stereological quantification of cell proliferation in the 
granular zone and hilus of aged rats at 3 days post-injury after LFPI. a) In 
the ipsilateral GZ (GCL and SGZ), vehicle-treated animals showed 
significantly enhanced cell proliferation compared to shams (*p<0.05). 
Animals treated with minocycline 30 minutes post-TBI and 4 hours post-TBI 
showed a reduced number of BrdU+ cells, which almost reached significance 
in the 4-hour treatment group. b) In the ipsilateral hilus, vehicle-treated 
animals had a significantly greater number of BrdU+ cells compared to shams 
(*p<0.05). Animals treated with minocycline 30 minutes post-TBI did not have 
a significantly different number of BrdU+ cells after injury compared to 
vehicles, but animals treated 4 hours post-TBI showed a reduction in the 
injury-induced proliferative response that almost reached significance.  
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THE EFFECT OF MINOCYCLINE ON NEUROGENESIS IN YOUNG ADULT AND 
AGED RATS FOLLOWING LFPI 
To examine the effect of minocycline on neurogenesis, DCX staining was used to 
quantify the number of newly generated neurons. New neurons are constantly 
generated in the DG and new neurons express DCX for 2 weeks after generation.  In 
our study, animals were sacrificed at 3 days post-injury, and at this time injury-induced 
new neurons were still at the early stage and lacking typical dendrites.  DCX+ cells that 
have vertical dendrites are likely new neurons born before injury, in contrast, DCX+ cells 
that have not identifiable dendrites or with horizontal and mixed dendrites are likely new 
neurons born after or around the time of TBI (Figure 3-6).  
In 3 month-old rats, stereological quantification showed that the number of DCX-
positive cells bearing horizontal or mixed dendrites was significantly increased in the 
ipsilateral DG after LFPI in animals treated with minocycline at 30 minutes or 4 hours 
post-TBI (p < 0.01; Figure 3-7a).   There were no significant differences in the numbers 
of DCX-positive cells in the DG between the two treatment groups or in the number of 
DCX-positive cells in vehicle-treated animals compared to sham animals. A decrease in 
the number of DCX-positive cells with vertical dendrites was observed in injured animals 
with or without minocycline treatment but was not statistically significant (Figure 3-7a). 
These data indicate that post-TBI administration of minocycline results in a significantly 
increased number of injury-induced new neurons in the DG of young rats after LPFI in 
both treatment time points.  
In the 20 month-old rats, stereological quantification of DCX-positive cells in the 
ipsilateral DG showed a significantly higher number of DCX-positive cells with horizontal 
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and mixed dendrites in rats treated with minocycline starting at 30 minutes post-LFPI 
compared to vehicles and shams (p < 0.01). Animals treated with minocycline 4 hours 
post-TBI did not demonstrate an increased number of DCX-positive cells in the DG 
following LFPI, and had significantly less DCX-positive cells with horizontal and mixed 
dendrites than rats treated with minocycline 30 minutes post-TBI (p < 0.05, Figure 3-7b).  
Quantification of the number of DCX+ cells with vertical dendrites revealed a significant 
reduction in animals with minocycline treatment in both groups compared to vehicles or 
sham animals (p < 0.01, Figure 3-7b).  
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Figure 3-6. Newly generated DCX+ neurons in the DG at 3 days post-injury in 
young and aged rats following LFPI. Micrographs taken from DCX-stained coronal 
sections in the ipsilateral DG from LFPI injured animals at 3 or 20 months showing 
many DCX+ cells in the 3 month brain compared to aged brain.   
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Figure 3-7. Quantitative analysis of the number of newly generated DCX+ 
neurons in 3 and 20 month old rats in the ipsilateral DG at 3 days 
following LFPI. a) In the 3 month old animal, a significantly higher number of 
DCX+ new neurons with horizontal or mixed dendrites was observed in 
animals treated with minocycline either starting at 30 minutes or 4 hours post-
TBI compared to vehicles and shams (**p<0.01).  No significant difference in 
the number of DCX+ neurons was found between the two treatment groups.  
A lower number of DCX+ cells with vertical dendrites were observed in all 
injury groups compared to sham, but did not reach statistical significance. b) 
In the 20 month old animals, a significantly higher number of DCX+ cells with 
horizontal or mixed dendrites was observed in animals treated with 
minocycline starting at 30 minutes post-TBI compared to vehicles and shams 
(**p<0.01) and compared to animals treated with minocycline starting at 4 
hours post-TBI (*p<0.05). Additionally, a reduced number of DCX+ cells with 
vertical dendrites was observed in animals in both minocycline treated groups 
compared to vehicles and shams (**p<0.01). 
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 STUDY 2: EFFECT OF MINOCYCLINE TREATMENT IN CCI MODEL  
MORTALITY RATE AND RIGHTING TIME FOLLOWING CCI INJURY 
 To assess the effect of minocycline on cell proliferation and neurogenesis after 
CCI, a total of twelve young rats and twelve aged rats were used. The mortality rate in 
young rats was 10% and in aged rats was 0%. The righting response was recorded 
immediately after injury as a measure of injury severity (Hamm, 2001). The mean 
("SEM) righting time for young rats after CCI was 4.29 "#0.60 minutes for minocycline-
treated animals and 3.38 ± 0.71 minutes for vehicle-treated animals, which were not 
statistically different (p = 0.59). The mean (±SEM) righting time for aged rats after CCI 
was 5.63 ± 0.53 minutes for minocycline-treated animals and 4.25 ± 0.25 minutes for 
vehicle-treated animals. This difference was also not statistically significant, indicating 
that all animals received a similar severity of injury (p = 0.13).# 
 THE EFFECT OF MINOCYCLINE ON CELL PROLIFERATION IN YOUNG 
ADULT AND AGED RATS FOLLOWING CCI INJURY 
In the 3-month old rats, very few BrdU-positive cells were observed in the 
ipsilateral DG of the sham animals.  Following CCI injury, more BrdU-positive cells were 
found in the vehicle-treated animals following CCI compared sham or injured with 
minocycline treatment either starting at 30 minutes or 4 hours post-TBI (Figure 3-8). 
Stereological quantification showed that the total number of BrdU+ cells was not 
significantly different among sham, CCI-vehicle or CCI-minocycline groups.  There were 
no significant differences in the number of BrdU-positive cells in the ipsilateral GZ or 
hilus between the two minocycline treatment groups (Figure 3-9).  
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In the aged rats, very few BrdU-positive cells were observed in the ipsilateral DG 
of the sham animals.   Following injury a large number of BrdU-positive cells was 
observed in the GZ and hilus in vehicle-treated animals compared to shams after CCI 
injury (p < 0.05 in GZ, p < 0.01 in hilus; Figure 3-10 and Figure 3-11). There was no 
significant difference in the number of BrdU-positive cells in the GZ and hilus of animals 
treated with minocycline at 30 minutes post-TBI compared to vehicles. Similarly, while 
the animals treated with minocycline 4 hours post-TBI showed a decreased number of 
BrdU-positive cells in the GZ and hilus compared to vehicles, this difference did not 
reach statistical significance (Figure 3-10 and Figure 3-11). There was no significant 
difference in the number of BrdU+ cells in the GZ and the hilus of animals between 
treatment groups. These data indicate that minocycline treatment tends to reduce the 
injury-induced proliferative response in aged rats following CCI injury, but this reduction 
in BrdU-positive cells in treated groups does not reach statistical significance. 
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Figure 3-8. Newly generated cells in the DG at 3 days post-injury in young rats 
following CCI injury. Micrographs taken from BrdU-stained coronal sections in the 
ipsilateral DG from a) sham animals, b) injured vehicle-treated animals, c) animals 
treated with minocycline 30 minutes post-TBI, and d) animals treated with 
minocycline 4 hours post-TBI. (a) very few BrdU+ cells were observed in the sham. 
(b) CCI injury resulted in a greatly enhanced number of BrdU+ cells in the DG, but 
minocycline treatment 30 minutes post-TBI (c) and 4 hours post- TBI (d) caused a 
reduction in the injury-induced cell proliferative response.  
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 Figure 3-9. Stereological quantification of cell proliferation in the 
granular zone and hilus of young rats at 3 days post-injury after CCI. a) 
In the ipsilateral GZ, a higher number of BrdU+ cells was observed in the 
vehicle-treated animals compared to shams, but did not reach significance. 
Animals treated with minocycline both 30 minutes and 4 hours post-TBI 
showed a reduction in the injury-induced proliferative response, but this also 
did not reach significance. b) In the ipsilateral hilus, vehicle-treated animals 
had a greater number BrdU+ cells compared to shams, but were not 
statistically significant. Animals in both minocycline treatment groups showed 
a decreased number of BrdU+ cells compared to vehicles, but did not reach 
statistical significance. There was no significant difference in the number of 
BrdU+ cells between treatment groups. 
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Figure 3-10. Newly generated cells in the DG at 3 days post-injury in aged rats 
following CCI Injury. Micrographs taken from BrdU-stained coronal sections in the 
ipsilateral DG from a) sham animals, b) injured vehicle-treated animals, c) animals 
treated with minocycline 30 minutes post-TBI, and d) animals treated with 
minocycline 4 hours post-TBI. (a) In the sham animal, there were very few BrdU+ 
cells in the ipsilateral DG. (b) Much more BrdU+ cells were observed in the DG of the 
vehicle-treated animal after CCI injury. (c-d) Less BrdU+ cells were observed in 
minocycline treated animals.  
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Figure 3-11. Stereological quantification of cell proliferation in the granular 
zone and hilus of aged rats at 3 days post-injury after CCI. (a) In the ipsilateral 
GZ, injured animals with vehicle or minocycline at 30 min had a significantly higher 
number of BrdU+ cells compared to shams (*p<0.05). Animals treated with 
minocycline starting at 4 hours post-TBI showed a reduced number of BrdU+ cells 
compared to vehicles, no statistical significance was reached compared to vehicles 
after CCI. (b) In the ipsilateral hilus, vehicle-treated animals showed a significantly 
enhanced number of BrdU+ cells compared to shams (**p<0.01). Animals treated 
with minocycline 4 hours post-TBI had a lower number of newly proliferating BrdU+ 
cells compared to vehicles, but there were no significant differences in the number of 
BrdU+ cells in either treatment group compared to vehicles. There were no significant 
differences in the number of BrdU+ cells in the GZ or hilus between two treatment 
groups.  
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THE EFFECT OF MINOCYCLINE ON NEUROGENESIS IN YOUNG ADULT AND 
AGED RATS FOLLOWING CCI INJURY 
In the 3 month-old animals, following CCI injury, the number of DCX-positive 
cells with horizontal and mixed dendrites was significantly higher in vehicle or 
minocycline treated groups when compared to shams (p < 0.01, Figure 3-12a). The 
number of DCX+ cells with vertical dendrites was slightly lower in the injured groups but 
was not statistically significant.   
In the aged rats, a higher number of DCX-positive cells with horizontal and mixed 
dendrites was found in rats treated with minocycline at 30 minutes or 4 hours after CCI 
injury compared to vehicles, but this enhanced neurogenesis was not significant in 
either treatment group compared to vehicles (Figure 3-12b). However, injured animals 
treated with minocycline had significantly more DCX+ cells compared to shams (p < 
0.01 in CCI-mino at 30 min; p < 0.05 in CCI-mino at 4 hr). There was a significant 
decrease in the number of DCX+ cells with vertical dendrites in the injured animals with 
vehicles or minocycline treatment as compared to shams (p < 0.05). No significant 
difference was found in the number of DCX+ cells with vertical dendrites among injured 
groups.  
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Figure 3-12. Quantitative analysis of the number of newly generated 
neurons in the ipsilateral DG of young and aged rats at 3 days following 
CCI. a) In the ipsilateral DG of young adult rats, animals treated with vehicle 
or minocycline starting either at 30 minutes or 4 hours post-TBI showed a 
significantly higher number of DCX+ cells compared to shams (**p<0.01). No 
significant difference was found in the number of DCX+ cells with vertical 
dendrites among all groups. b) In the ipsilated DG of aged rats, injured 
animals treated with vehicle or minocycline had a higher number of DCX+ 
cells with horizontal and mixed dendrites compared to shams, and this 
increase was statistically significant in animals treated 30 minutes post-TBI 
(**p<0.01) and in animals treated 4 hours post-TBI (*p<0.05). A significantly 
lower number of DCX+ cells with vertical dendrites was found in all injured 
animals compared shams (*p<0.05), but not among injured groups. 
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CHAPTER 4 – DISCUSSION 
RESULTS SUMMARY 
In this study, young adult and aged rats were subjected to mild to moderate LFPI 
or CCI injury followed by a short-term minocycline treatment. The animals that received 
minocycline treatment were randomly assigned to one of two treatment groups. Animals 
in treatment group 1 received a first 45 mg/kg dose of minocycline at 30 minutes post-
TBI, then a second 45 mg/kg dose 8 hours post-TBI. Animals in treatment group 2 
received a first 45 mg/kg minocycline dose at 4 hours post-TBI, followed by a second 45 
mg/kg dose at 8 hours post-TBI. Both groups received two 22.5 mg/kg minocycline 
treatments 12 hours apart on days 1 and 2 post-injury. The animals were sacrificed at 3 
days post-injury to assess the effects of minocycline on cell proliferation and 
neurogenesis in the DG of the hippocampus using BrdU and DCX staining. 
Following LFPI, both 3 month and aged animals show increased cell proliferation 
in the ipsilateral GZ and hilus regions compared to sham animals.  Minocycline 
treatment starting at 30 min or 4 hr post injury decreased the injury-induced cell 
proliferation in both age groups, although this reduction did not reach statistical 
significance likely due to the big standard errors within the group.  Minocycline 
treatment increased the number of newly generated neurons as characterized by 
horizontal or mixed dendrites with DCX staining in both young and aged animals.  This 
treatment effect was significant when minocycline was given at both time points in 
young adult animals and at 30 min post-injury in aged animals.  Minocycline treatment 
did not increase the number of DCX+ cells with vertical dendrites in both age groups, 
but rather decreased the number of this type of cells in the aged groups.    
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Following a mild to moderate CCI injury, all injured animals both young and aged 
with minocycline treatment had a reduced number of BrdU+ cells in the ipsilateral GZ 
and hilus region, but the reduction did not reach statistical significance similar to the 
LFPI model.  In this model, minocycline treatment slightly increased generation of new 
neurons with DCX+ horizontal and mixed dendrites in the aged but not young rats.   
TBI INDUCES AN INCREASED PROLIFERATIVE RESPONSE IN THE DG IN 
BOTH YOUNG AND AGED RATS 
It has been reported that NSC/NPCs are present in the adult mammalian brain 
and are stimulated to rapidly proliferate in response to brain insults in what appears to 
be an attempt of the brain to heal itself naturally after injury (Rice et al., 2003). In this 
study, in the LFPI injury model, young and aged rats had increased cell proliferation in 
response to injury in animals with vehicle treatment compared to shams. This response 
is consistent with studies reported in our lab and others which have shown that injury-
induced cell proliferation in the adult brain peaks at 2 days post-injury in the DG (Sun et 
al., 2005; Dash et al., 2001; Chirumamilla et al., 2002; Rice et al., 2003). Although 
NSC/NPCs are present throughout adulthood, studies have confirmed a major reduction 
in the number of these cells in the aged brain. This reduction was thought to contribute 
to the declined cognitive function observed in the elderly population (Dash et al., 2001; 
Artegiani and Calegari, 2012). In our current study, we found that the aged brain 
showed a significantly increased number of proliferating cells in the DG following either 
LFPI or CCI injury as compared to their age-matched shams.  This suggests that the 
aged brain retains proliferative capacity in the DG.  Following CCI injury, in the young 
animals the number of BrdU+ proliferation cells was not significantly higher than sham 
 89 
animals in the GZ and hilus, which is contrary to what has been reported before (Dast 
et. al., 2002).  This is likely due to the lower animal numbers included.  
MINOCYCLINE REDUCES THE INJURY-INDUCED PROLIFERATIVE 
RESPONSE 
Studies from our lab have shown that in the hippocampus in adult animals, many 
injury-induced proliferative cells are astrocytes and microglia (Chirumamilla et al., 
2002). Neuronal differentiation of newly generated cells was only observed in the 
neurogenic region of the SGZ (Dash et al., 2001). In the aged brain, there is significantly 
less neural progenitor proliferation, neuronal differentiation, and survival of new neurons 
compared to the younger brain, and newly proliferating cells in the aged animals 
differentiate predominantly into glial cells compared to young adult animals (Lee et al., 
2012).  
Inflammation is a strong inhibitor of neurogenesis and is heightened in the aged 
hippocampus. The concentration of activated microglia and secretion of pro-
inflammatory cytokines in the brain increases with age. It has been reported that 
activated microglia from aged mice exhibit increased secretion of pro-inflammatory 
cytokines TNF-# and IL-6 compared to young mice, which is consistent with other 
studies suggesting that the aged brain exhibits an amplified inflammatory response 
when stimulated (Lee et al., 2012). Recently, our lab has observed that the aged brain 
retains cell proliferative capacity following TBI, but this injury-induced proliferative 
response predominantly generates microglial cells.  In addition, we found that new 
neurons generated in the aged brain failed to survive for an extended period of time. We 
speculate that the amplified injury-induced inflammation in the aged brain may play a 
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critical role in modulating neurogenesis and cognitive function, and that inhibition of this 
injury-induced inflammatory response may restore the hippocampal neurogenic 
response and ultimately improve cognitive function of the injured aged animals. 
In this study, minocycline, a widely used tetracycline antibiotic, was used to 
inhibit the injury-induced inflammatory response.  Minocycline has anti-inflammatory 
effects inhibiting neutrophils, monocytes, and microglial cells (Elewa et al., 2006). In a 
stroke model, minocycline was reported to decrease the microglial response in the DG, 
preserve stroke-induced newly born hippocampal neurons, and reduce functional 
impairment (Liu et al., 2007). Minocycline was also reported to protect neurons in an 
acute toxin model of Parkinson’s disease where neuronal damage was predominantly 
caused by inflammation. Administration of minocycline in an immune-inflammatory 
encephalitis model resulted in decreased TNF-# release and enhanced secretion of 
anti-inflammatory cytokine IL-10. Additionally, the anti-inflammatory effect of 
minocycline have been observed in humans, as minocycline has been used to treat 
rheumatoid arthritis and multiple sclerosis (Elewa et al., 2006). Collectively, these 
studies suggest that minocycline has potential to modulate the inflammatory cascades 
induced by TBI and as a result enhance neurogenesis following injury, especially in 
aged patients where the inflammatory response is amplified.  
In this study, both young and aged rats subjected to LFPI and CCI showed a 
reduced injury-induced proliferative response after minocycline treatment starting at 30 
minutes or 4 hours post-TBI. Since the proliferative response in young adult rats, and 
especially aged rats, is predominately either microglia or astrocytes, these data are 
consistent with other studies that have reported reduced microglial activation after 
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minocycline treatment.  While there were no statistically significant differences in the 
number of BrdU-positive cells in the ipsilateral DG between minocycline treatment 
groups in each age group and injury model, the reduction in the proliferative response to 
injury appeared to be more marked in the animals treated with minocycline at 4 hours 
post-TBI.  
MINOCYCLINE ENHANCES NEUROGENESIS IN YOUNG AND AGED 
ANIMALS FOLLOWING LFPI 
The aged brain exhibits lower levels of neurogenesis than its younger 
counterpart, which may contribute to learning and memory impairments associated with 
aging. However, neurogenesis in the aged brain can be increased or even restored to 
levels observed in the adult brain by several factors, including an enriched environment 
and infusion of growth factors. Additionally, despite the age-associated decline in 
hippocampal neurogenesis, studies suggest that age-related causes of reduced 
neurogenesis do not affect the morphological properties of newly generated neurons, 
which is important from a therapeutic perspective (Ahlenius et al., 2009).  
The role of neuroinflammation in modulating neurogenesis is not fully 
understood. It appears that microglia in the normal brain are necessary to preserve 
neurogenesis and memory function, but microglia activated after brain insult impedes 
neurogenesis. It has been reported that LPS-induced inflammation resulted in an 85% 
reduction in the number of newly generated neurons during the inflammatory induction 
in young adult rats. Additionally, systematic administration of LPS was found to increase 
microglial activation and reduce neurogenesis, and this effect could be prevented by 
anti-inflammatory treatment with nonsteroidal anti-inflammatory drug (NSAID) 
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indomethacin. Microglia-mediated inflammation can regulate neurogenesis in two major 
ways. They have the potential to be neurotoxic when they are removing dysfunctional or 
damaged cells by producing reactive oxygen species and inflammatory cytokines 
(Gemma et al., 2010). Microglia are the major producers of the key innate cytokines IL-
1" and TNF-# which are pro-inflammatory cytokines and capable of inhibiting NSCs 
from differentiating into neurons (Lee et al., 2012). We speculated that inhibition of 
microglia-mediated inflammation with minocycline would enhance neurogenesis, 
especially in aged rats where microglial activation is amplified. 
In this study, both young adult and aged rats subjected to LFPI and treated with 
minocycline exhibited a reduction in the number of proliferating cells compared to the 
injured vehicle group. Additionally, minocycline-treated young and aged rats showed an 
increased number of new neurons as demonstrated by DCX+ cells bearing horizontal or 
mixed dendrites.  This is likely due to the inhibition of injury-induced microglia 
proliferation and subsequent reduced inflammation. In our study, in young animals, 
minocycline given beginning at 30 min or 4 hr after injury equally reduces cell 
proliferation and increases DCX+ cells following LFPI injury but not CCI injury, whereas 
in the aged animals minocycline treatment starting at 30 min post-injury has a more 
positive effect in increasing the number of young DCX+ neurons. This suggests that 
there are model and age-related differences in the injury-induced cell proliferative and 
neurogenic responses. While inflammatory cell responses vary depending on injury 
model (Loane and Byrnes, 2010), similarities and differences in microglial responses 
and temporal cytokine profiles in the LFPI and CCI model have not been well 
documented. These results also suggest varying pharmacokinetics of minocycline 
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treatment by age or other factors that affect stem/progenitor cell function, neuronal 
differentiation, or survival after injury (Gemma et al., 2010).  
We speculated that aged animals would exhibit higher levels of neurogenesis 
after injury with minocycline treatment due to the enhanced inflammation observed in 
the aged brain relative to the younger brain. However, young adult animals also showed 
a reduced cell proliferative response and enhanced neurogenesis following LFPI injury, 
suggesting that minocycline may influence neurogenesis via another mechanism. In 
addition to their anti-inflammatory and anti-oxidant properties, tetracyclines such as 
minocycline have also been shown to have anti-tumor properties. Minocycline inhibits 
cell proliferation by altering the cell cycle to arrest cells in the G0-G1 phase (Pourgholami 
et al., 2012). It is possible that by suppressing cell proliferation in this way, minocycline 
may drive early differentiation of cells into a neuronal phenotype in younger animals. 
Furthermore, we found that both young and aged injured animals with or without 
minocycline treatment have a lower number of DCX+ cells with vertical dendrites 
compared to their age-matched shams following both LFPI and CCI injury. Most DCX+ 
neurons bearing vertical dendrites are new neurons born before injury and they are 
vulnerable to TBI.  This injury-induced reduction indicated the loss of these new 
neurons due to the injury. Importantly, the decreased number of DCX+ cells with vertical 
dendrites in injured animals was significant in aged animals but not young animals after 
both LFPI and CCI injury. These results are consistent with other studies that have 
reported increased apoptotic cell death in the hippocampus of aged rats compared to 
young adult rats following brain injury (Itoh, 2012). Further, infarct development 
progresses at an accelerated rate in aged rats compared to young rats, which is linked 
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to apoptosis and early neuronal death as well as neuroinflammation. The rapid infarct 
progression and cell death in the aged brain following TBi is at least in part due to free 
radicals and oxidative stress, which also increases with age (Itoh, 2012; Popa-Wagner 
et al., 2011). The increased vulnerability of brain tissue to TBI with age is consistent 
with the neuronal loss observed in vehicle-treated aged animals.  
Minocycline-treated animals were expected to have less neuronal loss than 
vehicle animals due to the neuroprotective properties commonly attributed to 
minocycline, yet this effect was not observed. Recent studies have shown that 
minocycline has variable and even contradictory effects based on the species and 
model of neurological disorder. For example, minocycline has demonstrated 
neuroprotective effects in rodent models of ischemic injury and in global and focal 
cerebral ischemia (Diguet, 2004). In contrast, other studies have reported that 
minocycline had no effect on cell apoptosis in a mouse model of closed head injury 
(Bye, 2006) and had deleterious effects in Parkinson’s, Huntington’s, and hypoxic-
ischemic brain injury models (Diguet, 2004). Although the neuroprotective properties of 
minocycline are likely associated with its anti-inflammatory properties and inhibition of 
caspase pathways, further exploration of the mechanisms of minocycline in different 
injury models would be useful in understanding its varying effects (Diguet, 2004).   
Initially in this study, the effect of minocycline treatment on cell proliferation and 
neurogenesis was to be observed in the LFPI model only, as previous studies in our 
laboratory have been conducted using this model. However, Fisher 344 rats are highly 
sensitive to LFPI, and have been reported to exhibit higher mortality rates, more 
frequent seizure attacks, higher ICP, and more cell death than Sprague-Dawley rats of 
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the same age and subjected to the same injury level (Reid, 2010). Due to the high 
mortality rates observed early in the study, we slightly lowered the target injury level to 
increase survival rates following injury, especially in the aged rats that are particularly 
susceptible to LFPI. This adjustment in LFPI injury severity is responsible for the low 
mortality rates in the aged rats and the greater variation in LFPI injury results. The CCI 
injury model was included in this study because Fisher 344 rats are better able to 
tolerate the focal injury, as demonstrated by the almost complete lack of mortality 
following injury in both young and aged rats. For this reason, the CCI injury was more 
consistent among rats and produced more consistent results.  
FUTURE OF MINOCYCLINE AS A POTENTIAL THERAPY 
In this study, both young and aged rats showed a reduced injury-induced cell 
proliferative response after treatment with minocycline in both LFPI and CCI injury 
models. Furthermore, this reduction of injury-induced cell proliferation was concomitant 
with enhanced hippocampal neurogenesis in both young and aged rats following injury. 
While not all of these relationships showed statistical significance, the animals in the 
groups that did not reach significance showed a high degree of variability in 
stereological cell counts, which may have contributed to the lack of statistical 
significance in these groups. However, these groups showed a trend towards 
significance.  
There were no statistically significant differences between minocycline treatment 
groups in either cell proliferation or generation of new neurons in young or aged rats 
after CCI or in young rats after LFPI, but aged rats treated with minocycline at 30 
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minutes post-LFPI showed significantly enhanced neurogenesis compared to those 
treated at 4 hours post-LFPI. The animals treated 4 hours post-TBI tended to show a 
more marked reduction of the injury-induced cell proliferative response than the animals 
treated 30 minutes post-TBI. The more effective minocycline treatment to enhance 
neurogenesis differed among age and injury model groups. However, enhanced 
neurogenesis was observed in all groups that showed a significant reduction of the 
injury-induced proliferative response. These varying results may be due to differing 
minocycline pharmacokinetics in rats of different ages or in response to different types 
of injuries.  Due to the big variations, addition of more animal numbers to each group 
may reduce the observed variability in stereological counts and help identify the most 
effective minocycline treatment for the groups in this study. Importantly, this study 
identified the efficacy of minocycline treatment to reduce the number of injury-induced 
proliferating cells. Further study to confirm this reduced cell population is indeed 
microglia cells is needed.  Overall, the data from this study shows that minocycline 
treatment can enhance hippocampal neurogenesis in both LFPI and CCI injury models 
concomitant to reduced injury-induced cell proliferation. These data strongly support 
that microglia-mediated inflammation is detrimental to injury-induced neurogenesis, and 
that inhibition of this inflammatory response may result in improved cognitive recovery in 
patients. Future studies should also investigate the long-term effect of minocycline on 
cell survival, neuronal differentiation, and inflammation.  
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